Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability Rebound ⢠Strong Cash Flow ⢠Balance Sheet Risk HNGE's strong quarterly profitability and cash flow mark a major turnaround, but elevated valuation, dilution, and legacy balance-sheet deficits warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Strong monthly gain ⢠Resistance test ⢠Pullback support Support Level: $92.30â$92.70 Resistance Level: $94.80â$94.90 HNGE gained 10.8% over the last month and remains bullish above its average, but traders should watch for a sustained break above $94.90 or a pullback toward $92.30â$92.70.
Sentiment & News
Key News Insights: ⢠Technical Support ⢠Heavy Insider Selling ⢠Short Interest HNGE shows technical momentum and short-squeeze interest, but significant insider and institutional selling warrants caution.
AI Summary
HNGE has reached a compelling profitability and cash-flow inflection, but at ~52x EV/EBITDA near all-time highs, investors should require continued upside in core MSK growth and margin durability before adding aggressively; Cylinder is upside optionality, not yet a proven value driver.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 17 | Jun 24 | HNGE | Hinge Health, Inc. | Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment. | Closed | +5.3% |
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Closed | +2.3% |